Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €40.60 | €50.00 | 23.153% |
| Pro-Dex Inc. | 12 | 0 | 0 | 0 | €17.20 | - | - |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | €116.80 | €124.97 | 6.998% |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | €16.20 | €24.44 | 50.835% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €207.80 | €204.50 | -1.588% |
| Fresenius Medical Care AG & Co KGaA ST | 3 | 0 | 0 | 0 | €37.27 | €50.00 | 34.156% |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €1.97 | €4.00 | 103.046% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | €2.36 | €4.39 | 86.388% |
| UCB S.A. | 1 | 0 | 0 | 0 | €150.60 | - | - |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €25.89 | €35.01 | 35.208% |
| Myriad Genetics | 4 | 3 | 0 | 0 | €25.60 | €22.15 | -13.487% |
| Novavax Inc. | 4 | 1 | 0 | 1 | €15.80 | €22.18 | 40.341% |
| US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €88.00 | €108.77 | 23.601% |
| Patterson Companies Inc. | 8 | 0 | 0 | 0 | €24.00 | €31.22 | 30.064% |
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | €55.00 | €83.92 | 52.575% |
| Halozyme Therapeutics Inc. | 20 | 0 | 0 | 0 | €52.28 | €55.13 | 5.459% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.08 | - | - |
| Insulet Corp. | 17 | 0 | 0 | 0 | €175.00 | €216.46 | 23.692% |
| Masimo Corp. | 7 | 1 | 0 | 0 | €98.68 | €147.62 | 49.591% |
| Codexis Inc. | 6 | 1 | 0 | 0 | €3.36 | €8.36 | 148.638% |
| Horizon Pharma plc | 2 | 0 | 0 | 0 | €110.40 | - | - |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | €45.40 | €48.75 | 7.378% |